Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest, 27627-27628 [2018-12651]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 114 / Wednesday, June 13, 2018 / Notices
United States agents or distributors for
certain magnetic data storage tapes and
cartridges containing the same that
infringe the ’891 patent.
On May 9, 2018, Fujifilm filed a
complaint requesting that the
Commission institute a formal
enforcement proceeding under
Commission Rule 210.75 to investigate
alleged violation of the CDOs by Sony.
On May 23, 2018, Sony filed a letter
requesting that the Commission
determine not to institute the
enforcement proceeding. On May 30,
2019, Fujifilm filed a response.
Having examined the enforcement
complaint, the supporting documents,
and the pre-institution correspondence,
the Commission has determined to
institute a formal enforcement
proceeding, pursuant to 19 CFR
210.75(a), to determine whether a
violation of the March 8, 2018 CDOs
issued in the original investigation has
occurred and to determine what, if any,
enforcement measures are appropriate.
The named respondents are the three
Sony entities from the original
investigation and Sony Storage Media
Solutions Corporation of Tokyo, Japan;
Sony Storage Media Manufacturing
Corporation of Miyagi, Japan; Sony
DADC US Inc. of Terre Haute, Indiana;
and Sony Latin America Inc. of Miami,
Florida. OUII is also named as a party.
The Commission has not ruled on the
issues raised in the pre-institution
correspondence submitted by the
parties.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in Part
210 of the Commission’s Rules of
Practice and Procedure (19 CFR part
210).
By order of the Commission.
Issued: June 7, 2018.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2018–12655 Filed 6–12–18; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
amozie on DSK3GDR082PROD with NOTICES1
Notice of Receipt of Complaint;
Solicitation of Comments Relating to
the Public Interest
U.S. International Trade
Commission.
ACTION: Notice.
AGENCY:
Notice is hereby given that
the U.S. International Trade
Commission has received a complaint
entitled Certain Convertible Sofas and
SUMMARY:
VerDate Sep<11>2014
18:01 Jun 12, 2018
Jkt 244001
Components Thereof, DN 3321; the
Commission is soliciting comments on
any public interest issues raised by the
complaint or complainant’s filing
pursuant to the Commission’s Rules of
Practice and Procedure.
FOR FURTHER INFORMATION CONTACT: Lisa
R. Barton, Secretary to the Commission,
U.S. International Trade Commission,
500 E Street SW, Washington, DC
20436, telephone (202) 205–2000. The
public version of the complaint can be
accessed on the Commission’s
Electronic Document Information
System (EDIS) at https://edis.usitc.gov,
and will be available for inspection
during official business hours (8:45 a.m.
to 5:15 p.m.) in the Office of the
Secretary, U.S. International Trade
Commission, 500 E Street SW,
Washington, DC 20436, telephone (202)
205–2000.
General information concerning the
Commission may also be obtained by
accessing its internet server at United
States International Trade Commission
(USITC) at https://www.usitc.gov. The
public record for this investigation may
be viewed on the Commission’s
Electronic Document Information
System (EDIS) at https://edis.usitc.gov.
Hearing-impaired persons are advised
that information on this matter can be
obtained by contacting the
Commission’s TDD terminal on (202)
205–1810.
SUPPLEMENTARY INFORMATION: The
Commission has received a complaint
and a submission pursuant to § 210.8(b)
of the Commission’s Rules of Practice
and Procedure filed on behalf of Sauder
Manufacturing Company on June 7,
2018. The complaint alleges violations
of section 337 of the Tariff Act of 1930
(19 U.S.C. 1337) in the importation into
the United States, the sale for
importation, and the sale within the
United States after importation of
certain convertible sofas and
components thereof. The complaint
names as a respondent: Krug, Inc. of
Canada. The complainant requests that
the Commission issue a limited
exclusion order, a cease and desist
order, and impose a bond upon
respondents’ alleged infringing articles
during the 60-day Presidential review
period pursuant to 19 U.S.C. 1337(j).
Proposed respondents, other
interested parties, and members of the
public are invited to file comments, not
to exceed five (5) pages in length,
inclusive of attachments, on any public
interest issues raised by the complaint
or § 210.8(b) filing. Comments should
address whether issuance of the relief
specifically requested by the
complainant in this investigation would
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
27627
affect the public health and welfare in
the United States, competitive
conditions in the United States
economy, the production of like or
directly competitive articles in the
United States, or United States
consumers.
In particular, the Commission is
interested in comments that:
(i) Explain how the articles
potentially subject to the requested
remedial orders are used in the United
States;
(ii) identify any public health, safety,
or welfare concerns in the United States
relating to the requested remedial
orders;
(iii) identify like or directly
competitive articles that complainant,
its licensees, or third parties make in the
United States which could replace the
subject articles if they were to be
excluded;
(iv) indicate whether complainant,
complainant’s licensees, and/or third
party suppliers have the capacity to
replace the volume of articles
potentially subject to the requested
exclusion order and/or a cease and
desist order within a commercially
reasonable time; and
(v) explain how the requested
remedial orders would impact United
States consumers.
Written submissions must be filed no
later than by close of business, eight
calendar days after the date of
publication of this notice in the Federal
Register. There will be further
opportunities for comment on the
public interest after the issuance of any
final initial determination in this
investigation.
Persons filing written submissions
must file the original document
electronically on or before the deadlines
stated above and submit 8 true paper
copies to the Office of the Secretary by
noon the next day pursuant to § 210.4(f)
of the Commission’s Rules of Practice
and Procedure (19 CFR 210.4(f)).
Submissions should refer to the docket
number (‘‘Docket No. 3321) in a
prominent place on the cover page and/
or the first page. (See Handbook for
Electonic Filing Procedures, Electronic
Filing Procedures).1 Persons with
questions regarding filing should
contact the Secretary (202–205–2000).
Any person desiring to submit a
document to the Commission in
confidence must request confidential
treatment. All such requests should be
directed to the Secretary to the
Commission and must include a full
1 Handbook for Electronic Filing Procedures:
https://www.usitc.gov/documents/handbook_on_
filing_procedures.pdf.
E:\FR\FM\13JNN1.SGM
13JNN1
27628
Federal Register / Vol. 83, No. 114 / Wednesday, June 13, 2018 / Notices
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. All such requests
should be directed to the Secretary to
the Commission and must include a full
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. All information,
including confidential business
information and documents for which
confidential treatment is properly
sought, submitted to the Commission for
purposes of this Investigation may be
disclosed to and used: (i) By the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of this or a related proceeding, or (b) in
internal investigations, audits, reviews,
and evaluations relating to the
programs, personnel, and operations of
the Commission including under 5
U.S.C. Appendix 3; or (ii) by U.S.
government employees and contract
personnel,2 solely for cybersecurity
purposes. All nonconfidential written
submissions will be available for public
inspection at the Office of the Secretary
and on EDIS.3
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and of §§ 201.10 and 210.8(c) of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.10, 210.8(c)).
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 13, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
delegated to the Assistant Administrator
of the DEA Diversion Control Division
(‘‘Assistant Administrator’’) pursuant to
section 7 of 28 CFR part 0, appendix to
subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on May
3rd, 2018, Alcami Wisconsin
Corporation, W130 N10497 Washington
Dr., Germantown, WI 53022 applied to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
SUPPLEMENTARY INFORMATION:
Controlled
substance
By order of the Commission.
Issued: June 7, 2018.
Lisa Barton,
Secretary to the Commission.
Drug code
Thebaine ...........
Alfentanil ...........
[FR Doc. 2018–12651 Filed 6–12–18; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
9333
9737
Schedule
II
II
The company plans to provide bulk
active pharmaceutical ingredient to
support clinical trials.
Dated: June 6, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–12684 Filed 6–12–18; 8:45 am]
[Docket No. DEA–392]
BILLING CODE 4410–09–P
amozie on DSK3GDR082PROD with NOTICES1
Bulk Manufacturer of Controlled
Substances Application: Alcami
Wisconsin Corporation
ACTION:
Notice of application.
2 All
contract personnel will sign appropriate
nondisclosure agreements.
3 Electronic Document Information System
(EDIS): https://edis.usitc.gov.
VerDate Sep<11>2014
18:01 Jun 12, 2018
Jkt 244001
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Gazelle A. Craig, D.O.; Decision and
Order
Control Division, Drug Enforcement
Administration (hereinafter, DEA or
Government), issued an Order to Show
Cause to Gazelle A. Craig, D.O.
(hereinafter, Respondent), of Houston,
Texas. GX 2 (Order to Show Cause). The
Show Cause Order proposed the
revocation of Respondent’s Certificate of
Registration on the ground that she does
‘‘not have authority to handle controlled
substances in the State of Texas, the
[S]tate in which . . . [she is] registered
with the DEA.’’ Id. at 1 (citing 21 U.S.C.
823(f) and 824(a)(3)).
As to the Agency’s jurisdiction, the
Show Cause Order alleged that
Respondent holds DEA Certificate of
Registration No. FC1384306, which
authorizes her to dispense controlled
substances in schedules II through V as
a practitioner, at the registered address
of Gulfton Community Health Center,
6306 Gulfton St., Suite 101, Houston,
Texas 77081. Id. The Show Cause Order
alleged that this registration expires on
August 31, 2018. Id.
As the substantive ground for the
proceeding, the Show Cause Order
alleged that Respondent is ‘‘without
authority to handle controlled
substances in the State of Texas, the
[S]tate in which . . . [she is] registered
. . . with the DEA.’’ Id. It further
alleged that, on July 28, 2017, the Texas
Medical Board temporarily suspended
Respondent’s medical license and that
the Texas Medical Board order remains
in effect. Id. The Show Cause Order
asserted that Respondent is ‘‘required to
possess authority from a [S]tate in order
to obtain or retain a DEA
Registration. . . . [and c]onsequently,
the DEA must revoke . . . [her
registration] based upon [her] lack of
authority to handle controlled
substances in the State of Texas.’’ Id. at
1–2.
The Show Cause Order notified
Respondent of her right to request a
hearing on the allegations or to submit
a written statement while waiving her
right to a hearing, the procedures for
electing each option, and the
consequences for failing to elect either
option. Id. at 2 (citing 21 CFR 1301.43).
The Show Cause Order also notified
Respondent of the opportunity to
submit a Corrective Action Plan. Id. at
2–3 (citing 21 U.S.C. 824(c)(2)(C)).
On September 20, 2017, the Acting
Assistant Administrator, Diversion
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
E:\FR\FM\13JNN1.SGM
13JNN1
]]>Agencies
[Federal Register Volume 83, Number 114 (Wednesday, June 13, 2018)]
[Notices]
[Pages 27627-27628]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-12651]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
Notice of Receipt of Complaint; Solicitation of Comments Relating
to the Public Interest
AGENCY: U.S. International Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the U.S. International Trade
Commission has received a complaint entitled Certain Convertible Sofas
and Components Thereof, DN 3321; the Commission is soliciting comments
on any public interest issues raised by the complaint or complainant's
filing pursuant to the Commission's Rules of Practice and Procedure.
FOR FURTHER INFORMATION CONTACT: Lisa R. Barton, Secretary to the
Commission, U.S. International Trade Commission, 500 E Street SW,
Washington, DC 20436, telephone (202) 205-2000. The public version of
the complaint can be accessed on the Commission's Electronic Document
Information System (EDIS) at https://edis.usitc.gov, and will be
available for inspection during official business hours (8:45 a.m. to
5:15 p.m.) in the Office of the Secretary, U.S. International Trade
Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 205-
2000.
General information concerning the Commission may also be obtained
by accessing its internet server at United States International Trade
Commission (USITC) at https://www.usitc.gov. The public record for this
investigation may be viewed on the Commission's Electronic Document
Information System (EDIS) at https://edis.usitc.gov. Hearing-impaired
persons are advised that information on this matter can be obtained by
contacting the Commission's TDD terminal on (202) 205-1810.
SUPPLEMENTARY INFORMATION: The Commission has received a complaint and
a submission pursuant to Sec. 210.8(b) of the Commission's Rules of
Practice and Procedure filed on behalf of Sauder Manufacturing Company
on June 7, 2018. The complaint alleges violations of section 337 of the
Tariff Act of 1930 (19 U.S.C. 1337) in the importation into the United
States, the sale for importation, and the sale within the United States
after importation of certain convertible sofas and components thereof.
The complaint names as a respondent: Krug, Inc. of Canada. The
complainant requests that the Commission issue a limited exclusion
order, a cease and desist order, and impose a bond upon respondents'
alleged infringing articles during the 60-day Presidential review
period pursuant to 19 U.S.C. 1337(j).
Proposed respondents, other interested parties, and members of the
public are invited to file comments, not to exceed five (5) pages in
length, inclusive of attachments, on any public interest issues raised
by the complaint or Sec. 210.8(b) filing. Comments should address
whether issuance of the relief specifically requested by the
complainant in this investigation would affect the public health and
welfare in the United States, competitive conditions in the United
States economy, the production of like or directly competitive articles
in the United States, or United States consumers.
In particular, the Commission is interested in comments that:
(i) Explain how the articles potentially subject to the requested
remedial orders are used in the United States;
(ii) identify any public health, safety, or welfare concerns in the
United States relating to the requested remedial orders;
(iii) identify like or directly competitive articles that
complainant, its licensees, or third parties make in the United States
which could replace the subject articles if they were to be excluded;
(iv) indicate whether complainant, complainant's licensees, and/or
third party suppliers have the capacity to replace the volume of
articles potentially subject to the requested exclusion order and/or a
cease and desist order within a commercially reasonable time; and
(v) explain how the requested remedial orders would impact United
States consumers.
Written submissions must be filed no later than by close of
business, eight calendar days after the date of publication of this
notice in the Federal Register. There will be further opportunities for
comment on the public interest after the issuance of any final initial
determination in this investigation.
Persons filing written submissions must file the original document
electronically on or before the deadlines stated above and submit 8
true paper copies to the Office of the Secretary by noon the next day
pursuant to Sec. 210.4(f) of the Commission's Rules of Practice and
Procedure (19 CFR 210.4(f)). Submissions should refer to the docket
number (``Docket No. 3321) in a prominent place on the cover page and/
or the first page. (See Handbook for Electonic Filing Procedures,
Electronic Filing Procedures).\1\ Persons with questions regarding
filing should contact the Secretary (202-205-2000).
---------------------------------------------------------------------------
\1\ Handbook for Electronic Filing Procedures: https://www.usitc.gov/documents/handbook_on_filing_procedures.pdf.
---------------------------------------------------------------------------
Any person desiring to submit a document to the Commission in
confidence must request confidential treatment. All such requests
should be directed to the Secretary to the Commission and must include
a full
[[Page 27628]]
statement of the reasons why the Commission should grant such
treatment. See 19 CFR 201.6. Documents for which confidential treatment
by the Commission is properly sought will be treated accordingly. All
such requests should be directed to the Secretary to the Commission and
must include a full statement of the reasons why the Commission should
grant such treatment. See 19 CFR 201.6. Documents for which
confidential treatment by the Commission is properly sought will be
treated accordingly. All information, including confidential business
information and documents for which confidential treatment is properly
sought, submitted to the Commission for purposes of this Investigation
may be disclosed to and used: (i) By the Commission, its employees and
Offices, and contract personnel (a) for developing or maintaining the
records of this or a related proceeding, or (b) in internal
investigations, audits, reviews, and evaluations relating to the
programs, personnel, and operations of the Commission including under 5
U.S.C. Appendix 3; or (ii) by U.S. government employees and contract
personnel,\2\ solely for cybersecurity purposes. All nonconfidential
written submissions will be available for public inspection at the
Office of the Secretary and on EDIS.\3\
---------------------------------------------------------------------------
\2\ All contract personnel will sign appropriate nondisclosure
agreements.
\3\ Electronic Document Information System (EDIS): https://edis.usitc.gov.
---------------------------------------------------------------------------
This action is taken under the authority of section 337 of the
Tariff Act of 1930, as amended (19 U.S.C. 1337), and of Sec. Sec.
201.10 and 210.8(c) of the Commission's Rules of Practice and Procedure
(19 CFR 201.10, 210.8(c)).
By order of the Commission.
Issued: June 7, 2018.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2018-12651 Filed 6-12-18; 8:45 am]
BILLING CODE 7020-02-P
